| Company | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Fulcrum Therapeutics, Inc. | VP Finance & Accounting | Stock Option (right to buy) | 40,000 | 19 Jan 2022 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Role | Filing Time |
|---|---|---|---|---|---|---|---|
| FULC | Fulcrum Therapeutics, Inc. | 19 Jan 2022 | 1 | $0 | 4 | VP Finance & Accounting | 21 Jan 2022, 15:15 |
| FULC | Fulcrum Therapeutics, Inc. | 28 Jun 2021 | 1 | +$20,700 | 4 | VP Finance & Accounting | 29 Jun 2021, 16:15 |